Switch to a Broader-Spectrum Antibiotic Immediately
If cephalexin is not working for your respiratory infection, you need to switch to an antibiotic that covers atypical pathogens and beta-lactamase-producing bacteria, such as amoxicillin-clavulanate, a macrolide (azithromycin or clarithromycin), a fluoroquinolone (levofloxacin or moxifloxacin), or doxycycline.
Why Cephalexin May Be Failing
Cephalexin is a first-generation oral cephalosporin with significant limitations for respiratory infections. The FDA label explicitly states that cephalexin has poor activity against Haemophilus influenzae, one of the most common respiratory pathogens 1. Additionally, cephalexin does not cover atypical organisms (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella) which are frequent causes of community-acquired respiratory infections 2.
Common pitfall: Cephalexin is often inappropriately prescribed for respiratory infections when it should be reserved primarily for skin/soft tissue infections. Research confirms that cephalexin's spectrum "reduces its uses in the pediatric population and may limit its effectiveness in some patients with acute exacerbations of chronic bronchitis" due to H. influenzae resistance 3.
Recommended Next Steps
1. Assess Severity and Consider Hospital Referral
Before changing antibiotics, determine if you need hospital evaluation. Seek immediate medical attention if you have 2:
- Respiratory rate >30 breaths/minute
- Oxygen saturation <92% on room air
- Confusion or altered mental status
- Systolic blood pressure <90 mmHg
- Temperature >38.5°C (101.3°F) or <35°C (95°F)
- Multilobar infiltrates on chest X-ray
2. Obtain Diagnostic Testing for Treatment Failure
Guidelines specifically recommend investigations when first-line empirical therapy fails 2:
- Sputum culture and Gram stain (recommended)
- Blood white cell count and C-reactive protein (recommended)
- Chest X-ray if not already done
- Blood cultures if fever >38°C or pneumonia suspected
3. Switch to Appropriate Antibiotic Coverage
For outpatient management of treatment failure 2, 4:
First-line options:
- Amoxicillin-clavulanate 875-125 mg twice daily (or 2000-125 mg twice daily for high-dose formulation)
- Covers S. pneumoniae, beta-lactamase-producing H. influenzae, and M. catarrhalis
Alternative options:
Azithromycin 500 mg day 1, then 250 mg daily for 4 days OR Clarithromycin 500 mg twice daily
- Covers atypical pathogens (Mycoplasma, Chlamydophila, Legionella)
Levofloxacin 750 mg daily OR Moxifloxacin 400 mg daily
- Broad coverage including pneumococci, H. influenzae, and atypicals
- Reserve for patients with recent antibiotic use, chronic lung disease, or risk factors for resistant organisms 4
Doxycycline 100 mg twice daily
- Good atypical coverage, cost-effective option
Duration: Treat for 5-7 days for bronchitis/mild pneumonia; up to 8 days for pneumonia 2, 4.
4. Specific Scenarios
If you have chronic lung disease or recent antibiotic use 2:
- High risk for beta-lactamase-producing H. influenzae
- Use amoxicillin-clavulanate or fluoroquinolone as first choice
If young adult during Mycoplasma epidemic season 2:
- Macrolide (azithromycin/clarithromycin) or doxycycline preferred
If suspected aspiration or anaerobic infection 4:
- Amoxicillin-clavulanate or clindamycin + cephalosporin
Critical Timing
Reassess response at 48-72 hours after switching antibiotics 2, 4. You should see:
- Fever resolution within 48 hours
- Improvement in symptoms (though cough may persist longer)
- No progression of clinical signs
If still not improving after 48-72 hours on appropriate therapy, you need hospital evaluation for possible complications (empyema, abscess, resistant organisms, non-infectious causes) 2.
Key Caveat About Antibiotic Resistance
The guidelines emphasize that antibiotic choice should consider local resistance patterns 2, 4. In areas with high rates of macrolide-resistant S. pneumoniae (>25%), combination therapy (beta-lactam + macrolide) or fluoroquinolone monotherapy may be preferred over macrolide alone 4.
Bottom line: Cephalexin lacks the spectrum needed for most respiratory infections. Switching to amoxicillin-clavulanate, a macrolide, or a respiratory fluoroquinolone based on your specific risk factors will provide appropriate coverage for the likely pathogens causing treatment failure.